Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download1 - 6 of 9 results
A PBPK based simulation study to predict potential gastric transit time and permeability driven drug-drug interactions caused by Rybelsus®
18 December 2025Physiologically Based Biopharmaceutics Modelling of the Effect of a Permeability Enhancer on the Absorption of a Highly Soluble and Poorly Permeable Small Peptide in Humans
6 November 2024ACoP 2022 Poster: Benznidazole pharmacokinetics in adults and children: Application of PBPK modelling
13 December 2022Qualification of Gastroplus® PBPK modelling software to support decision-making in clinical development
13 December 2022AAPS 2019 Poster: Comparison of Two In-Silico Modeling Programs, ADMET Predictor® and Percepta® to Predict Intrinsic Solubility and pKa of Poorly Soluble Drugs
4 November 2019AAPS 2021: Development and Application of a PBPK Model Using Theoretical Particle Size Distribution to Describe in vivo D issolution to Predict the Impact of Formulation Changes on Oral Bioavailability of GB001
Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.